Clinical Trial Update: TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating TNF antagonist and glucocorticoid receptor antagonist for Gulf War Illness; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gulf War Illness

Drugs mentioned

• TNF antagonist and glucocorticoid receptor antagonist

Snippet

Sponsor: Nova Southeastern University | Conditions: Gulf War Illness | Phase 1 | Status: ACTIVE_NOT_RECRUITING